RxSight Down Over 13%, on Pace for Largest Percent Decrease Since June 2022 -- Data Talk

Dow Jones
2024-12-21

RxSight, Inc. $(RXST)$ is currently at $33.18, down $5.01 or 13.12%

 

--Would be lowest close since Dec. 5, 2023, when it closed at $32.99

--On pace for largest percent decrease since June 21, 2022, when it fell 16.36%

--Currently down three of the past four days

--Down 29.22% month-to-date

--Down 17.71% year-to-date; on pace for worst year on record (Based on available data back to July 30, 2021)

--Down 48.39% from its all-time closing high of $64.29 on May 15, 2024

--Down 16.30% from 52 weeks ago (Dec. 22, 2023), when it closed at $39.64

--Down 48.39% from its 52-week closing high of $64.29 on May 15, 2024

--Would be a new 52-week closing low

--Traded as low as $33.03; lowest intraday level since Dec. 6, 2023, when it hit $32.88

--Down 13.51% at today's intraday low; largest intraday percent decrease since Nov. 8, 2024, when it fell as much as 16.32%

 

All data as of 3:34:11 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

December 20, 2024 15:35 ET (20:35 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10